CIRM Funded Clinical Trials

Phase 1B/2A study of the safety and tolerability of human neural stem cells for Huntington’s Disease (REGEN4HD)

Disease Area:

Huntington's Disease

Investigator:

Dr. LESLIE M Thompson

Institution:

University of California, Irvine

CIRM Grant:

CLIN2-18595 (Pre-Active)

Award Value:

$11,999,933.00

Trial Sponsor:

University of California, Irvine

Trial Stage:

Phase 1/2

Trial Status:

Launching

Targeted Enrollment:

N/A

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.